News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
358,103 Results
Type
Article (20354)
Company Profile (128)
Press Release (337621)
Section
Business (113166)
Career Advice (882)
Deals (20296)
Drug Delivery (93)
Drug Development (52935)
Employer Resources (79)
FDA (8339)
Job Trends (8015)
News (198730)
Policy (18519)
Tag
Academia (774)
Alliances (30704)
Alzheimer's disease (644)
Antibody-drug conjugate (ADC) (73)
Approvals (8326)
Artificial intelligence (111)
Bankruptcy (173)
Best Places to Work (5772)
Biosimilars (75)
Breast cancer (102)
Cancer (864)
Cardiovascular disease (81)
Career advice (714)
Cell therapy (130)
Clinical research (44010)
Collaboration (366)
Compensation (107)
COVID-19 (1172)
C-suite (94)
Data (866)
Diabetes (118)
Diagnostics (2167)
Drug pricing (101)
Earnings (41378)
Employer resources (73)
Events (51234)
Executive appointments (343)
FDA (8771)
Funding (254)
Gene therapy (115)
GLP-1 (538)
Government (1915)
Healthcare (6411)
Infectious disease (1232)
Inflammatory bowel disease (78)
Interviews (115)
IPO (8064)
Job creations (2501)
Job search strategy (652)
Layoffs (263)
Legal (4415)
Lung cancer (135)
Lymphoma (69)
Manufacturing (171)
Medical device (2865)
Medtech (2869)
Mergers & acquisitions (12405)
Metabolic disorders (402)
Neuroscience (887)
NextGen: Class of 2025 (2451)
Non-profit (937)
Northern California (880)
Obesity (255)
Opinion (181)
Patents (95)
People (34757)
Pharmaceutical (73)
Phase I (13739)
Phase II (18698)
Phase III (14899)
Pipeline (413)
Policy (83)
Postmarket research (1657)
Preclinical (4850)
Radiopharmaceuticals (168)
Rare diseases (197)
Real estate (3399)
Regulatory (13137)
Research institute (846)
Resumes & cover letters (138)
Southern California (809)
Startups (2193)
United States (8222)
Vaccines (242)
Weight loss (210)
Date
Today (56)
Last 7 days (334)
Last 30 days (1462)
Last 365 days (18586)
2025 (1508)
2024 (18813)
2023 (21039)
2022 (28348)
2021 (29272)
2020 (27267)
2019 (21480)
2018 (16666)
2017 (18569)
2016 (17506)
2015 (20333)
2014 (16098)
2013 (13763)
2012 (14773)
2011 (15092)
2010 (13837)
Location
Africa (424)
Asia (33646)
Australia (4390)
California (2024)
Canada (977)
China (274)
Colorado (80)
Connecticut (82)
Europe (55694)
Florida (318)
Illinois (203)
Indiana (144)
Japan (92)
Maryland (328)
Massachusetts (1723)
Minnesota (132)
New Jersey (789)
New York (631)
North Carolina (432)
Northern California (880)
Pennsylvania (472)
South America (650)
Southern California (809)
Texas (266)
Washington State (175)
358,103 Results for "medison pharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
Medison Pharma and Alnylam Pharmaceuticals, Inc. announced a further expansion of their existing partnership in Central & Eastern Europe and Israel, to also include selected markets in LATAM and APAC and additional international markets.
April 30, 2024
·
5 min read
Press Releases
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
December 25, 2024
·
1 min read
Business
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries
Medison Pharma announced their exclusive multi-national agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc., a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases, to commercialize Libtayo®, a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells, in select European markets and additional markets around the world.
January 8, 2024
·
5 min read
Press Releases
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
December 11, 2024
·
3 min read
Policy
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)
Ipsen and Medison Pharma are pleased to announce the Health Canada approval for Bylvay™ for the treatment of pruritus in patients aged 6 months or older with Progressive Familial Intrahepatic Cholestasis, a progressive and life-threatening liver disease.
November 13, 2023
·
13 min read
Deals
Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma
Essential Pharma announces that it has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd.
April 9, 2024
·
5 min read
Press Releases
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
November 18, 2024
·
7 min read
Press Releases
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
December 2, 2024
·
6 min read
Press Releases
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
December 13, 2024
·
11 min read
Press Releases
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
December 12, 2024
·
5 min read
1 of 35,811
Next
